Abuse of Buprenorphine in the United States

References

• Costae , J A Silva . 2004 . Medicines and the drug control treaties: Is buprenorphine for opioid addiction at risk of being lost? . Hum Psychopharmacol Clin Exp , 19 : 215 – 224 .
   PubMedGoogle Scholar
• Drug Addiction Treatment Act of 2000, Public Law 106–310, Title XXXV (DA. T. A., 2000). Federal Food, Drug, and Cosmetic Act. (Act) 21 U.S.C. § 360, Section 510.
   Google Scholar
• U.S. Food and Drug Administration. FDA Talk Paper: Subutex® and Suboxone® approved to treat opioid dependence. T08–38; October, 8. 2002. Available at: http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01165.hjtml. Last accessed: November 15, 2006.
   Google Scholar
• Tzchenske , T M . 2002 . Behavioral pharmacology of burprenorphine with a focus on preclinical models of reward and addiction . Psychopharmacology , 161 : 1 – 16 .
   PubMedGoogle Scholar
• Auriacombe , M , Fatsea , M , Dubernet , J , Daulouede , J P and Tignol , J . 2001 . French field experience with buprenorphine . Am J Addict , 13 ( Suppl. 1 ) : S17 – 28 .
   Google Scholar
• Guichard , A , Lert , F , Calderon , C , Gaigi , H , Maguet , O , Soletti , J , Brodeur , J-M , Richard , L , Benigeri , M and Zunzunegui , M-V . 2003 . Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France . Addiction , 98 : 1585 – 1597 .
   PubMed Web of Science ®Google Scholar
• Jenkinson , R A , Clark , N C , Fry , C L and Dobbin , M . 2005 . Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? . Addiction , 100 : 197 – 205 .
   PubMed Web of Science ®Google Scholar
• Obadia , Y , Perrin , V , Feroni , I , Vlahov , D and Moatti , J-P . 2001 . Injecting misuse of buprenorphine among French drug users . Addiction , 96 : 267 – 272 .
   PubMed Web of Science ®Google Scholar
• Parfitt , T . 2006 . Designer drug Subutex takes its toll in Tbilisi . Lancet , 368 : 273 – 274 .
   PubMed Web of Science ®Google Scholar
• Winslow , M , Ng , W-L , Mythily , S , Song , G and Yiiong , H-C . 2006 . Socio-demographic profile and help-seeking behavior of buprenorphine abusers in Singapore . Ann Acad Med Singapore , 35 : 451 – 456 .
   PubMedGoogle Scholar
• Alho , H , Sinclair , D , Vuori , E and Holopainen , A . 2006 . Abuse liability of buprenorphine-naloxone tabletsin untreated IV drug users . Drug Alcohol Depend , 22 : 533 – 541 .
   Google Scholar
• Smith , M Y , Dart , R , Hughes , A , Geller , A , Senay , E , Woody , G and Colucci , S . 2006 . Clinician validation of poison control center (PCC) intentional exposure cases involving prescription opioids . Am J Drug Alcohol Abuse , 32 : 465 – 478 .
   PubMed Web of Science ®Google Scholar
• IMS Health Inc . 2003–2005 . Xponent Database-in retail pharmacies and mail order
   Google Scholar
• Zacny , J , Bigelow , G , Compton , P , Foley , K , Iguchi , M and Sannerud , C . 2003 . College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement . Drug Alcohol Depend , 69 : 215 – 232 .
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Administration, Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction Treatment Improvement Protocol (TIP) 40, 2004. Available at www.kap.samhsa.gov. (Last accessed, 04/13/07).
   Google Scholar
• Strain , E C , Stoller , K M , Walsh , S L and Bigelow , G E . 2000 . The effects of buprenorphine and buprenorphine/naloxone tablets in non-dependent opioid abusers . Psychopharmacology , 148 : 374 – 383 .
   PubMed Web of Science ®Google Scholar
• Subutex® Suboxone®; [package insert]. Reckitt-Benickser Pharmaceuticals. Richmond, VA.
   Google Scholar